Additionally, the use of ATR (ataxia telangiectasia and Rad3-related protein) inhibitors alongside PARP inhibitors has been shown to further intensify replication stress and drive tumor cell apoptosis in certain cancer models [66, 70]. Here, ATR is linked to neoplasm.